SLC5A2 and psoriasis: Furthermore, there are emerging data that suggest that several antihyperglycemic agents used in the treatment of type 2 diabetes have beneficial effects on psoriasis, including biguanides, sodium-glucose cotransporter-2 (SGLT-2) inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and thiazolidinediones.